The Discounted Cash Flow (DCF) valuation of Vifor Pharma AG (VIFN.SW) is 150.54 CHF. With the latest stock price at 166.15 CHF, the upside of Vifor Pharma AG based on DCF is -9.4%.
Based on the latest price of 166.15 CHF and our DCF valuation, Vifor Pharma AG (VIFN.SW) is a sell. selling VIFN.SW stocks now will result in a potential gain of 9.4%.
| Range | Selected | |
| WACC / Discount Rate | 4.3% - 6.5% | 5.4% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 84.86 - 1,312.52 | 150.54 |
| Upside | -48.9% - 690.0% | -9.4% |